| 000 | 01667 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518052444.0 | ||
| 264 | 0 | _c20210714 | |
| 008 | 202107s 0 0 eng d | ||
| 022 | _a1536-3686 | ||
| 024 | 7 |
_a10.1097/MJT.0000000000001014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSamoš, Matej | |
| 245 | 0 | 0 |
_aAnti-Xa Activity in Elderly Xabans-Treated Patients With Atrial Fibrillation. _h[electronic resource] |
| 260 |
_bAmerican journal of therapeutics _c |
||
| 300 |
_ae507-e509 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Observational Study | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xblood |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aFactor Xa Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aProduct Surveillance, Postmarketing _xstatistics & numerical data |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aPyridones _xadministration & dosage |
| 650 | 0 | 4 |
_aRivaroxaban _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aBolek, Tomáš | |
| 700 | 1 | _aŠkorňová, Ingrid | |
| 700 | 1 | _aStančiaková, Lucia | |
| 700 | 1 | _aUrban, Lukáš | |
| 700 | 1 | _aStaško, Ján | |
| 700 | 1 | _aGalajda, Peter | |
| 700 | 1 | _aKubisz, Peter | |
| 700 | 1 | _aMokáň, Marián | |
| 773 | 0 |
_tAmerican journal of therapeutics _gvol. 27 _gno. 5 _gp. e507-e509 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MJT.0000000000001014 _zAvailable from publisher's website |
| 999 |
_c29950569 _d29950569 |
||